Description

Body Protective Compound 157 (BPC-157) represents a synthetic pentadecapeptide originally isolated from human gastric juice and subsequently developed for research applications. The compound exhibits the molecular formula C62H98N16O22 with a molecular weight of 1419.5 g/mol and is catalogued in PubChem under CID 9941957. The peptide sequence consists of fifteen amino acids arranged as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, forming a stable molecular structure that demonstrates resistance to enzymatic degradation compared to other peptide compounds. The chemical stability of BPC-157 is attributed to its unique amino acid composition and sequence arrangement, which allows the peptide to maintain biological activity under various laboratory conditions. Current research status indicates that BPC-157 is under investigation in clinical trial NCT02637284, designated as PCO-02, which focuses on safety and pharmacokinetic evaluation.